120 related articles for article (PubMed ID: 11787854)
1. Promoter-specific transcription of the IGF2 gene: a novel rapid, non-radioactive and highly sensitive protocol for mRNA analysis.
Hartmann W; Waha A; Koch A; Albrecht S; Gray SG; Ekström TJ; von Schweinitz D; Pietsch T
Virchows Arch; 2001 Dec; 439(6):803-7. PubMed ID: 11787854
[TBL] [Abstract][Full Text] [Related]
2. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters.
Li X; Cui H; Sandstedt B; Nordlinder H; Larsson E; Ekström TJ
J Endocrinol; 1996 Apr; 149(1):117-24. PubMed ID: 8676043
[TBL] [Abstract][Full Text] [Related]
4. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.
Honda S; Arai Y; Haruta M; Sasaki F; Ohira M; Yamaoka H; Horie H; Nakagawara A; Hiyama E; Todo S; Kaneko Y
Br J Cancer; 2008 Dec; 99(11):1891-9. PubMed ID: 19034281
[TBL] [Abstract][Full Text] [Related]
7. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
9. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
[TBL] [Abstract][Full Text] [Related]
10. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
[TBL] [Abstract][Full Text] [Related]
11. High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma.
Fukuzawa R; Umezawa A; Ochi K; Urano F; Ikeda H; Hata J
Int J Cancer; 1999 Aug; 82(4):490-7. PubMed ID: 10404060
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma.
Akmal SN; Yun K; MacLay J; Higami Y; Ikeda T
Hum Pathol; 1995 Aug; 26(8):846-51. PubMed ID: 7543440
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
Li Y; Meng G; Huang L; Guo QN
Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
[TBL] [Abstract][Full Text] [Related]
14. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
Vu TH; Hoffman AR
Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
[TBL] [Abstract][Full Text] [Related]
15. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
16. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.
Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ
Exp Cell Res; 2001 Oct; 270(1):88-95. PubMed ID: 11597130
[TBL] [Abstract][Full Text] [Related]
17. Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour.
Taniguchi T; Schofield AE; Scarlett JL; Morison IM; Sullivan MJ; Reeve AE
Oncogene; 1995 Aug; 11(4):751-6. PubMed ID: 7651739
[TBL] [Abstract][Full Text] [Related]
18. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
Yballe CM; Vu TH; Hoffman AR
J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma.
Lawson EA; Zhang X; Crocker JT; Wang WL; Klibanski A
J Clin Endocrinol Metab; 2009 Jul; 94(7):2226-31. PubMed ID: 19383775
[TBL] [Abstract][Full Text] [Related]
20. GH is a regulator of IGF2 promoter-specific transcription in human liver.
von Horn H; Ekström C; Ellis E; Olivecrona H; Einarsson C; Tally M; Ekström TJ
J Endocrinol; 2002 Mar; 172(3):457-65. PubMed ID: 11874694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
